Aetna Extends Waivers for COVID-19-Related Care for Aetna Members

Aetna, a CVS Health company, has extended cost-share waivers for its fully insured members as part of continued steps to help members access the care they need during the COVID-19 pandemic.

Recommended AI News: Privitar Achieves Microsoft’s Co-Sell Ready Designation And Joins Microsoft Fast Track For ISVs Program

The extensions include:

• Waiving member cost-sharing for inpatient admissions for treatment of COVID-19 or health complications associated with COVID-19 for Commercial and Medicare Advantage plan members, through December 31, 2020.
• Waiving member cost-sharing for covered in-network telemedicine visits for outpatient behavioral and mental health counseling services for Commercial plan members, through December 31, 2020.
• Waiving member cost-sharing for in-network telemedicine visits for Medicare Advantage members for specialist visits, which includes mental and behavioral health providers, through December 31, 2020.
• Waiving Medicare Advantage member cost-sharing for all in-network primary care visits, whether done in-office and via telehealth, for any reason, through December 31, 2020.
• Waiving early refill limits on 30-day prescription maintenance medications for all members with pharmacy benefits administered through CVS Caremark, through December 31, 2020.
• Aetna continues to waive member cost-sharing for diagnostic testing related to COVID-19 for Commercial, Medicare and Medicaid members.

Recommended AI News: Silvaco Acquires Memory Compiler Technology Of Dolphin Design SAS

We are closely monitoring the progress of the pandemic, federal and state policies and the associated impact on our members, customers and providers. We’ll continue to adjust our policies, as appropriate, to ensure access to care.

Recommended AI News: QuoLab Technologies Announces Partnership With QGroup GmbH